NervGen Pharma Corp. (NGEN)
1.845
-0.08
(-3.91%)
USD |
NASDAQ |
Nov 20, 16:00
1.92
+0.08
(+4.07%)
After-Hours: 20:00
NervGen Pharma Total Return Level : 1.845 for Nov. 20, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 20, 2026 | 1.845 |
| November 19, 2026 | 1.92 |
| November 18, 2026 | 1.90 |
| November 17, 2026 | 1.96 |
| November 16, 2026 | 1.82 |
| November 13, 2026 | 1.88 |
| November 12, 2026 | 1.63 |
| November 11, 2026 | 1.35 |
| November 10, 2026 | 1.33 |
| November 09, 2026 | 1.395 |
| November 06, 2026 | 1.33 |
| November 05, 2026 | 1.32 |
| November 04, 2026 | 1.35 |
| November 03, 2026 | 1.32 |
| November 02, 2026 | 1.35 |
| October 30, 2026 | 1.37 |
| October 29, 2026 | 1.44 |
| October 28, 2026 | 1.50 |
| October 27, 2026 | 1.48 |
| October 26, 2026 | 1.42 |
| October 23, 2026 | 1.43 |
| October 22, 2026 | 1.42 |
| October 21, 2026 | 1.50 |
| October 20, 2026 | 1.54 |
| October 19, 2026 | 1.54 |
| Date | Value |
|---|---|
| October 16, 2026 | 1.59 |
| October 15, 2026 | 1.62 |
| October 14, 2026 | 1.565 |
| October 13, 2026 | 1.63 |
| October 12, 2026 | 1.73 |
| October 09, 2026 | 1.73 |
| October 08, 2026 | 1.75 |
| October 07, 2026 | 1.74 |
| October 06, 2026 | 1.75 |
| October 05, 2026 | 1.81 |
| October 02, 2026 | 1.78 |
| October 01, 2026 | 1.76 |
| September 30, 2026 | 1.91 |
| September 29, 2026 | 1.92 |
| September 28, 2026 | 1.88 |
| September 25, 2026 | 1.94 |
| September 24, 2026 | 2.02 |
| September 23, 2026 | 1.96 |
| September 22, 2026 | 2.065 |
| September 21, 2026 | 1.99 |
| September 18, 2026 | 2.05 |
| September 17, 2026 | 2.27 |
| September 16, 2026 | 2.13 |
| September 15, 2026 | 2.14 |
| September 14, 2026 | 2.195 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Milestone Pharmaceuticals, Inc. | 0.3711 |
| Appili Therapeutics, Inc. | 0.001 |
| Clearmind Medicine, Inc. | 2.630 |
| Lexaria Bioscience Corp. | 4.03 |
| Target Group, Inc. (Canada) | 0.0011 |